BSECompany Update3d ago · 22 Oct 2026, 01:01 pm
Medicine Authority European Union (EU)- conducted GMP inspection at Company''s Formulation manufacturing facility located at Khopoli is successfully concluded.
Kopran Ltd · 524280
✦ AI SummaryRegulatory
Kopran Ltd's formulation manufacturing facility at Khopoli successfully concluded a GMP inspection by the Medicine Authority European Union (EU) with one major and some minor observations.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk6/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Kopran Ltd - 524280 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Attachments (1)
📄pdf
Download →
471fe80c-3e0b-4123-a2f8-3e04b6982b32.pdf
View document text
October 22, 2026
The Manager The Manager
BSE Limited The National Stock Exchange of India Limited
Corporate Relationship Department Exchange Plaza,
P. J. Towers, Dalal Street, Bandra - Kurla Complex, Bandra (E),
Mumbai – 400 001. Mumbai – 400 051.
BSE Scrip Code No. 524280 NSE Symbol: KOPRAN
Subject: Press Release
Dear Sir/Madam,
“Closure of Medicine
Authority European Union (EU)- conducted GMP inspection at the Company’s Formulation
Please find enclosed a copy of press release dated October 22, 2026, titled
manufacturing facility located at Khopoli.”
This may kindly be considered as a disclosure pursuant to Regulation 30 of the SEBI (Listing
Obligations and Disclosure Requirements) Regulations, 2015.
Regards,
For Kopran Limited
Sunil Sodhani
Company Secretary & Compliance Officer
Membership No. FCS 3897
KOPRAN LTD.: Parijat House, 1076, Dr. E. Moses Road, Worli, Mumbai - 400 018. P. B. No. 9917, Tel.: (022) 4366 1111
Fax: (022) 2495 0363 Website: www.kopran.com CIN – L 24230 MH 1958 PLC 011078.Email: cs@kopran.com
Works:• Village Savroli, Taluka: Khalapur, District: Raigad - 410 202. Tel.: (02192) 274500 / 335 / 337• Fax: (02192) 274025
PRESS RELEASE
“Closure of Medicine Authority European Union (EU) conducted GMP inspection at the
Company’s Formulation manufacturing facility located at Khopoli.”
Medicine Authority European Union (EU)- conducted GMP inspection at the Company’s
Formulation, manufacturing facility located at Khopoli, from September 18, 2026 to
September 23, 2026.
The inspection was successfully concluded with No critical observations
, one major
observation and some minor observations and there were no data integrity related
observations.
The Company is in the process to submit the compliance responses to the EU authorities
within a fortnight
October 22, 2026
Mumbai
KOPRAN LTD.: Parijat House, 1076, Dr. E. Moses Road, Worli, Mumbai - 400 018. P. B. No. 9917, Tel.: (022) 4366 1111
Fax: (022) 2495 0363 Website: www.kopran.com CIN – L 24230 MH 1958 PLC 011078.Email: cs@kopran.com
Works:• Village Savroli, Taluka: Khalapur, District: Raigad - 410 202. Tel.: (02192) 274500 / 335 / 337• Fax: (02192) 274025